When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ABCL - Our First Assessment Of AbCellera Biologics
AbCellera Biologics Inc.
Shares of antibody discoverer AbCellera Biologics Inc. (ABCL) have fallen 80% from their all-time high as the market has thoroughly discounted its COVID-19 assets.
The pandemic showcased AbCellera’s discovery platform, but the speed to market and royalty participation percentages were complete outliers.
With 155 programs inked with 35 partners but only five antibodies approved or in the clinic, this busted IPO merited a deeper dive.
A full investment analysis follows in the paragraphs below.